Circulating Tumor Cells Market Growth Fueled by Rising Cancer Incidence | Major Companies are QIAGEN, Fluxion Biosciences, Inc., Greiner Bio One International GmbH

The Global Circulating Tumor Cells Market reached US$ 11.80 billion in 2023 and is expected to reach US$ 26.61 billion by 2031, growing at a CAGR of 11.1% during the forecast period 2024-2031.

Circulating Tumor Cells Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/circulating-tumor-cells-market?nrk

Circulating tumor cells (CTCs) are cancer cells that break away from the primary tumor and enter the bloodstream, playing a critical role in metastasis. Detecting and analyzing CTCs helps in early cancer diagnosis, treatment monitoring, and understanding disease progression. Liquid biopsy techniques enable non-invasive CTC detection, providing an alternative to traditional tissue biopsies. The CTC market is growing due to advancements in cancer research and personalized oncology. Emerging technologies aim to enhance CTC capture and analysis for improved clinical applications.

Market Dynamics:

The increasing number of cancer cases is one of the significant key factors that help the market to grow during the forecast period. For instance, according to the National Center for Health Statistics. In 2023, 1,958,310 new cancer cases and 609,820 cancer deaths are projected to occur in the United States. Cancer incidence increased for prostate cancer by 3% annually from 2014 through 2019 after two decades of decline, translating to an additional 99,000 new cases; otherwise, however, incidence trends were more favourable in men compared to women. As cancer prevalence rises, there is a growing need for effective cancer diagnostics and monitoring tools along with CTC-based assays and technologies. This presents a significant opportunity for companies operating in the market to develop innovative products and solutions that enable the detection, enumeration, and molecular characterization of CTCs.

Industry Development:

On January 3, 2025, researchers from the German Cancer Research Center (DKFZ) successfully cultivated stable tumor organoids from circulating tumor cells (CTCs) in breast cancer patients. This breakthrough allows for the study of therapy resistance and the development of targeted treatments. The organoids can be used to identify specific molecular pathways that support cancer cell survival, potentially leading to innovative therapeutic strategies tailored to individual patients. This method represents a significant advancement in understanding metastatic processes and could pave the way for personalized medicine in breast cancer treatment.

Key Players:

Thermo Fisher Scientific Inc, QIAGEN, Fluxion Biosciences, Inc., Greiner Bio One International GmbH, Ikonisys Inc., BioFluidica, Biolidics Limited, Creativ MicroTech Inc., Menarini Silicon Biosystems, StemCell Technologies.

Growth Forecast Projected:

The Global Circulating Tumor Cells Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Circulating Tumor Cells Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=circulating-tumor-cells-market

Market Segmentation:

By Product Type: Devices, Kits & Assays, Consumables

By Technology: CTC Detection and Enrichment Method, CTC Direct Detection Method, SERS, Microscopy, Others, CTC Analysis

By Application: Liquid Biopsy, Research, Clinical, Others

By Specimen: Blood, Bone Marrow, Others

By End User: Hospitals, Clinics, Diagnostic Centers, Others

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/circulating-tumor-cells-market

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the Circulating Tumor Cells market?

➠ Who are the leading manufacturers in the global Circulating Tumor Cells industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global Circulating Tumor Cells industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the Circulating Tumor Cells market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.